IDO2 and cancer: The possibility that indoleamine-2,3-dioxygenase may cause immune escape of various different tumors [52,53,54,55] has also been suggested, and that over-expression of indoleamine-2,3-dioxygenase in tumors may increase tryptophan metabolism, leading to a decreased of tryptophan in cancer patients.